Laboratoires Chemineau

What Laboratoires Chemineau does

Laboratoires Chemineau is a private French CDMO founded in 1947 and headquartered in Vouvray. It develops and manufactures topical, liquid, semi-solid, spray, and aerosol products for pharmaceutical companies, healthcare brands, cosmetics companies, and dietary-supplement businesses, with therapeutic emphasis on dermatology, women's health, pain relief, and respiratory/ORL applications. The company reports 320 collaborators, 27 production lines, 60 million units produced annually, and 300+ product references; 87% of revenue is attributed to pharmaceutical products and medical devices. It operates as a wholly owned subsidiary of ANJAC Group.

Chemineau's technical offer includes Emulpro, a patented next-generation micro-gellified oil-in-water emulsion platform with fewer than 10 INCI ingredients and 0.1–1% surfactant, plus a contamination-free process for BOV aerosols and metered-dose sprays. It has opened an ultra-clean GMP unit for R&D, pilot, and Phase I–III clinical batches, including rare-disease treatments, highly active materials at OEB6, liquid-to-semi-solid forms, and multiple primary-packaging options.

It offers full-service or à la carte engagements spanning pre-formulation, formulation, stability studies, development, industrial transfer, regulatory support, analytical method development and validation, clinical batches, and industrial/commercial production. Go-to-market is direct enterprise selling to business customers; pricing is not publicly disclosed and appears to be negotiated per project.

Name

Laboratoires Chemineau

Legal name

Laboratoires Chemineau

Website

https://chemineau.com

Company type

Private

Founded year

1947

Operating status

Operating

Headcount range

51–100 employees

Short description

French CDMO developing and manufacturing topical, dermatological, women’s health, pain-relief, and respiratory/ORL products for pharmaceutical companies, healthcare brands, cosmetics companies, and dietary-supplement businesses, from formulation through clinical and commercial production.

Ownership category

akta.pro rank

Product category

Pharmaceutical CDMO (Contract Development and Manufacturing)

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Small-Molecule API & Intermediates CDMO (HLAGABAA)

Keywords

• Pharmaceutical CDMO services
• Topical product manufacturing
• ORL pharmaceutical formulations
• Contract development manufacturing
• Aerosol and spray manufacturing

Headquarters

HQ city

Vouvray

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. CDMO Manufacturing Services: Contract development and manufacturing services for pharmaceutical products, medical devices, cosmetics, and dietary supplements in liquid, semi-solid, spray, and aerosol forms. Revenue generated through full-service or à la carte manufacturing engagements.
2. Formulation and Development Services: Pre-formulation, formulation, stability studies, development, industrial transposition, technology transfer, regulatory support, and analytical method development and validation services.
3. Clinical Batch Production: Production of clinical trial batches (Phase I, II, III) for R&D and pilot purposes, including rare disease treatments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Laboratoires Chemineau is a French contract development and manufacturing organization (CDMO) providing full-service or à la carte manufacturing of topical pharmaceutical products (creams, gels, emulsions) and ORL (ear, nose, throat) products including nasal sprays, throat sprays, and aerosols. Its offering spans pre-formulation, formulation, stability studies, industrial transposition, technology transfer, regulatory support, clinical batch production, and commercial manufacturing across dermatology, women's health, pain relief, and respiratory therapeutic areas. The company operates 27 production lines producing 60 million units per year.

Product overview

Laboratoires Chemineau operates as a CDMO (Contract Development and Manufacturing Organization) offering full-service or à la carte pharmaceutical manufacturing. Their core offerings include Emulpro (a patented micro-gelled oil-in-water emulsion platform), clinical batch production services, and contamination-free BOV/spray manufacturing technology. The company produces a comprehensive portfolio of topical and respiratory/ORL products organized into four main therapeutic areas: Dermatology (antibiotics, antiseptics, antifungals, anesthetics, anti-acne, anti-psoriasis, wound care), Women's Health (vaginal treatments, hormone therapy), Pain Relief (topical NSAIDs, hot/cold CBD/essential oil-based analgesics), and Respiratory/ORL (nasal hygiene, seawater, corticosteroids, throat treatments). Their services span pre-formulation, formulation, stability studies, industrial transposition, regulatory support, and commercial production across liquid, semi-solid, spray, and aerosol forms.

Differentiator

Problem solved

Functional benefit

Brands

• Emulpro: Patented next-generation platform that stabilizes actives while ensuring optimal tolerance for skin and mucous membranes in health and cosmetic applications. Micro gelified oil-in-water emulsion, natural and customized (less than 10 INCI ingredients), with very low surfactant content (0.1-1%), offering an ultra-tolerant base.

Products and services

• Emulpro Galenic Platform Proprietary patented formulation platform for developing dermatological, vaginal, and nasal pharmaceutical and cosmetic solutions with enhanced skin and mucous membrane tolerance and under 10 INCI ingredients.
• Clinical Batch Production Services Dedicated GMP ultra-clean unit for production of R&D, pilot, and clinical batches (Phase I, II, III), including rare disease medications in liquid to semi-solid forms with highly active materials (OEB6) and various primary packaging options.
• BOV Aerosol and Metered-Dose Spray Manufacturing Contamination-free manufacturing process for BOV aerosols and metered-dose sprays ensuring formula stability and packaging functionality, ideal for preservative-free products with maximum safety and quality.
• Full-Service CDMO Development and Manufacturing End-to-end contract development and manufacturing services for pharmaceutical products, medical devices, cosmetics, and dietary supplements in liquid, semi-solid, spray, and aerosol forms, available as full-service or à la carte engagements.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• ANJAC Groupparent companyOthersLaboratoires Chemineau is part of the ANJAC Group, a health and beauty company conglomerate. ANJAC Groups brings together complementary pharmaceutical and cosmetic manufacturing capabilities under one umbrella.

Scale indicators7 records

Recent moves3 records

Expansion highlights6 records

Direct peers

• Recipharm: Swedish-headquartered European CDMO operating multiple semisolid/liquid and aerosol manufacturing sites with similar topical and inhalation capabilities, directly comparable to Chemineau's service portfolio.
• Hovione: Portugal-based CDMO specializing in complex formulations, sprays, and highly potent compounds – directly overlapping with Chemineau's complex galenics, highly active, and nasal spray expertise.
• Fareva: French pharmaceutical and cosmetic CDMO with comparable topical, liquid, and aerosol manufacturing capabilities across health and beauty – a direct French competitor to Chemineau.
• Delpharm: French pharmaceutical CDMO focused on solid, liquid, and semi-solid dosage forms with deep European customer relationships – competes head-to-head with Chemineau for French pharma contract manufacturing work.
• NextPharma: European pharmaceutical CDMO with sterile, solid, semi-solid and clinical services targeted to mid-sized pharma – operates as a direct peer for outsourced topical and ORL production.
• Pillar5 Pharma: Canadian-headquartered CDMO specializing in semi-solid and liquid pharmaceutical manufacturing for dermatology and topical products – a close specialty peer focused on the same niche topical formulations as Chemineau.

Broad incumbents

• Catalent: Large global CDMO with established topical, softgel, and clinical supply services – a broad incumbent whose scale and breadth overlap Chemineau's offerings across multiple customers and programs.
• Aenova Group: European CDMO group offering solid, semi-solid, and liquid manufacturing across multiple sites – broader portfolio player competing with Chemineau for topical and specialty pharma contracts.
• CordenPharma: European CDMO with strength in complex APIs and highly potent drug products, including semi-solid and topical forms – broader incumbent that competes for the highly active (OEB-classified) work Chemineau targets.
• Aptar Pharma: Global drug-delivery device and component supplier (spray pumps, valves, BOV systems) closely tied to nasal/aerosol drug product manufacturing – adjacent incumbent with comparable spray/aerosol expertise to Chemineau's BOV and metered-dose offerings.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/laboratoires-chemineau-sa

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoires Chemineau